| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,714 | 20,481 | 20,115 | 21,966 | | Cost of Revenue | 3,793 | 4,195 | 4,636 | 5,363 | | | Gross Profit |
-
| 16,286 | 15,479 | 16,603 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,939 | 11,195 | 9,524 | 9,956 | | Non Recurring |
-
|
-
|
-
| 56,146 | | Others | 2,750 | 2,000 | 2,000 | 600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,091 | 3,955 | (50,099) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,232 | 3,091 | 3,955 | (50,099) | | Interest Expense | 336 | 348 | 351 | 449 | | Income Before Tax | 1,896 | 2,743 | 3,604 | (50,548) | | Income Tax Expense | 584 | 813 | 1,122 | (17,929) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,312 | 1,930 | 2,482 | (32,619) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,312 | 1,930 | 2,482 | (32,619) | | Preferred Stock And Other Adjustments | (430) | (428) | (205) |
-
| | | Net Income Applicable To Common Shares | $882 | $1,502 | $2,277 | ($32,619) |
|
0.40% Nasdaq 
0.04 (0.33%) 
Income Statement
